Innovating Works

PAVIMENTOS DE TUDELA

Activa
PanC-ASAP: AbilityPharma Accelerating Solutions for Pancreatic Cancer ABILITY PHARMACEUTICALS tramitó un H2020: H2020-EIC-SMEInst-2018-2020 ABTL0812 is a first-in-class fully differentiated oral targeted anticancer compound that produces autophagy-mediated cytotoxicity selectivel...
2020-06-24 - 2023-06-30 | Financiado
PLASMOfab: A generic CMOS compatible platform for co integrated plasmonics photonics electronics PICs towards v... ARISTOTELIO PANEPISTIMIO THESSALONIKIS tramitó un H2020: H2020-ICT-2015 PLASMOfab aims to address the ever increasing needs for low energy, small size, high complexity and high performance mass manufactured PICs...
2015-11-10 - 2018-12-31 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.